Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
-2.31% | -53.99% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cellular Immunotherapies
100.0
%
| 6 | 100.0 % | 2 | 100.0 % | -75.81% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 2 | 100.0 % | -75.81% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,901,026 | 11,716,439 ( 98.45 %) | 67,746 ( 0.5692 %) | 98.45 % |
Stock B | 0 | 452,000 | 0 | 0 |
Company contact information
Bellicum Pharmaceuticals, Inc.
3730 Kirby Drive Suite 1200
77098, Houston
+281 454 3424
http://www.bellicum.com![address Bellicum Pharmaceuticals, Inc.(BPXA)](https://cdn.zonebourse.com/static/address/50919217.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-53.99% | 822K | |
+20.12% | 127B | |
+25.25% | 117B | |
+25.56% | 27.77B | |
-19.51% | 20.44B | |
-14.36% | 16.62B | |
-15.63% | 15.92B | |
-46.67% | 14.94B | |
+11.89% | 14.74B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BPXA Stock
- Company Bellicum Pharmaceuticals, Inc.